Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238824 | 0.89 | ALDH1A1 (0.61) | L3MBTL1MAPTNPSR1ALDH1A1KDM4E | |
| SCHEMBL29510942 | 0.89 | ALDH1A1 (0.61) | L3MBTL1MAPTNPSR1ALDH1A1KDM4E | |
| SCHEMBL13552184 | 0.87 | ALDH1A1 (0.50) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL7821244 | 0.86 | LMNA (0.62) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL4920959 | 0.86 | L3MBTL1 (0.76) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL10337826 | 0.86 | IDO1 (0.68) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL5391790 | 0.86 | TSHR (0.49) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL10005200 | 0.86 | L3MBTL1 (0.50) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| SCHEMBL9440806 | 0.85 | CYP1A2 (0.60) | L3MBTL1MAPTNPSR1TDP1CYP1A2 | |
| 1,2-Diethoxybenzene SCHEMBL578986 | 0.83 | ALDH1A1 (0.68) | L3MBTL1MAPTNPSR1TDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878508-A | DC-Rhoin derivative, preparation method and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2024-11-01 | — | — | CN | claimed |
| EP-1786764-B1 | PROCESS FOR PREPARING TAMSULOSIN | SCINOPHARM SINGAPORE PTE LTD (SG) | 2017-03-15 | — | — | EP | claimed |
| US-7332621-B2 | Process for preparing Tamsulosin | SCINOPHARM TAIWAN KTD. (TW) | 2008-02-19 | — | — | US | claimed |
| US-20070142669-A1 | reacting o-ethoxyphenoxyethanol with sulfonyl chloride; reacting the sulfonate with (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide by condensation to produce Tamsulosin | SCINOPHARM TAIWAN LTD. | 2007-06-21 | — | — | US | claimed |
| EP-1786764-A2 | PROCESS FOR PREPARING TAMSULOSIN | Scinopharm Singapore Pte Ltd. (SG) | 2007-05-23 | — | — | EP | claimed |
| WO-2006019358-A2 | PROCESS FOR PREPARING TAMSULOSIN | SCINOPHARM SINGAPORE PTE LTD. (SG) | 2006-02-23 | — | — | WO | claimed |
| US-20060036113-A1 | Process for preparing tamsulosin | SCINOPHARM TAIWAN LTD. | 2006-02-16 | — | — | US | claimed |
| US-12286418-B2 | Compounds and methods for treating or preventing bacterial infections | BAYLOR COLLEGE OF MEDICINE (US) | 2025-04-29 | — | — | US | disclosed |
| CN-118878508-A | DC-Rhoin derivative, preparation method and application thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2024-11-01 | — | — | CN | disclosed |
| US-20220267303-A1 | Compounds and Methods for Treating or Preventing Bacterial Infections | BAYLOR COLLEGE OF MEDICINE | 2022-08-25 | — | — | US | disclosed |
| WO-2022149081-A1 | IMPROVED PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL IN THE PREPARATION OF ANTI-ANDROGENIC COMPOUND | OCIMUM LABS PRIVATE LIMITED (IN) | 2022-07-14 | — | — | WO | disclosed |
| WO-2022149081-A1 | IMPROVED PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL IN THE PREPARATION OF ANTI-ANDROGENIC COMPOUND | OCIMUM LABS PRIVATE LIMITED (IN) | 2022-07-14 | — | — | WO | disclosed |
| WO-2020257734-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING, AMELIORATING, OR PREVENTING BACTERIAL INFECTIONS | BAYLOR COLLEGE OF MEDICINE (US) | 2020-12-24 | — | — | WO | disclosed |
| EP-1697316-A1 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF (R)-TAMSULOSIN AND OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR THEIR PREPARATION | PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) | 2006-09-06 | — | — | EP | disclosed |
| WO-2006019358-A2 | PROCESS FOR PREPARING TAMSULOSIN | SCINOPHARM SINGAPORE PTE LTD. (SG) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006019358-A2 | PROCESS FOR PREPARING TAMSULOSIN | SCINOPHARM SINGAPORE PTE LTD. (SG) | 2006-02-23 | — | — | WO | disclosed |
| CN-1736984-A | Method for synthesizing tamsulosin medicine for resisting benign prostatic hyperplasia | SHENLONG SINGAPORE PRIVATE CO (SG) | 2006-02-22 | — | — | CN | disclosed |
| US-20060036113-A1 | Process for preparing tamsulosin | SCINOPHARM TAIWAN LTD. | 2006-02-16 | — | — | US | disclosed |
| US-20060036113-A1 | Process for preparing tamsulosin | SCINOPHARM TAIWAN LTD. | 2006-02-16 | — | — | US | disclosed |
| WO-2005058810-A1 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF (R)-TAMSULOSIN AND OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR THEIR PREPARATION | PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE (FR) | 2005-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267303-A1 | Compounds and Methods for Treating or Preventing Bacterial Infections | OXA1L, MMP8, OGG1 | L3MBTL1 120/4885MAPT 4642/4885NPSR1 4123/4885 |
| US-12286418-B2 | Compounds and methods for treating or preventing bacterial infections | OXA1L, MMP8, OGG1 | L3MBTL1 120/4885MAPT 4642/4885NPSR1 4123/4885 |
| US-20070142669-A1 | reacting o-ethoxyphenoxyethanol with sulfonyl chloride; reacting the sulfonate with (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide by condensation to produce Tamsulosin | BPHL, REN, MME | L3MBTL1 4853/4885MAPT 3424/4885NPSR1 22/4885 |
| US-20060036113-A1 | Process for preparing tamsulosin | BPHL, REN, TPSB2 | L3MBTL1 4878/4885MAPT 2010/4885NPSR1 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.